AstraZeneca may have provided incomplete efficacy data from latest COVID-19 trial: NIAID
British drugmaker AstraZeneca Plc may have provided an incomplete view of efficacy data on its COVID-19 vaccine from a large scale US trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said on Tuesday, in a fresh setback to the shot.
from bdnews24.com - Home https://ift.tt/3962mb3
from bdnews24.com - Home https://ift.tt/3962mb3
No comments